Pseudotumor cerebri presenting as headache

Expert Review of Neurotherapeutics

Volumn 8, Issue 3, 2008, Pages 397-407

  Friedman, Deborah I ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

Cerebrospinal fluid shunt; Headache disorder; Intracranial hypertension; Obesity; Papilledema; Pseudotumor cerebri; Secondary

Indexed keywords

ACETAZOLAMIDE; ANXIOLYTIC AGENT; BICARBONATE; CARBONATE DEHYDRATASE INHIBITOR; CORTICOSTEROID; DIHYDROERGOTAMINE; DIURETIC AGENT; ESTROGEN; FUROSEMIDE; GABAPENTIN; GESTAGEN; LEPTIN; METHAZOLAMIDE; PROSTAGLANDIN D SYNTHASE; RETINOL; TOPIRAMATE; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID; VERAPAMIL;

AGE DISTRIBUTION; ANXIETY; APLASTIC ANEMIA; ARNOLD CHIARI MALFORMATION; BICARBONATE BLOOD LEVEL; BRAIN PSEUDOTUMOR; CEREBRAL SINUS THROMBOSIS; CEREBROSPINAL FLUID EXAMINATION; CEREBROSPINAL FLUID PRESSURE; CHRONIC DAILY HEADACHE; CLOSED ANGLE GLAUCOMA; COMPUTER ASSISTED TOMOGRAPHY; CORTICOSTEROID THERAPY; DEPRESSION; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; DROWSINESS; DRUG CONTRAINDICATION; DRUG DOSE TITRATION; DRUG HYPERSENSITIVITY; EPIDEMIOLOGICAL DATA; EVIDENCE BASED MEDICINE; HEADACHE; HUMAN; INTRACRANIAL HYPERTENSION; MORBIDITY; NEPHROLITHIASIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OPHTHALMOSCOPY; PAPILLEDEMA; PARESTHESIA; PATHOGENESIS; PATHOPHYSIOLOGY; PATIENT COUNSELING; PHLEBOGRAPHY; PRACTICE GUIDELINE; PREGNANCY; PROGNOSIS; PSYCHOTHERAPY; QUALITY OF LIFE; RADICULOPATHY; REVIEW; SIDE EFFECT; SODIUM RESTRICTION; STEVENS JOHNSON SYNDROME; SYMPTOM; TASTE ACUITY; VISION; VISION TEST; VISUAL FIELD; VISUAL IMPAIRMENT;

COMBINED MODALITY THERAPY; DECOMPRESSION, SURGICAL; DIAGNOSIS, DIFFERENTIAL; HEADACHE; HUMANS; NERVE COMPRESSION SYNDROMES; OPHTHALMOSCOPY; OPTIC NERVE DISEASES; PAPILLEDEMA; PROGNOSIS; PSEUDOTUMOR CEREBRI; VISION DISORDERS;

EID: 41649104356     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/14737175.8.3.397     Document Type: Review

References (55)

1. Bandyopadhyay S. Pseudotumor cerebri. Arch. Neurol. 58, 1699-1701 (2001).
2. Friedman DI, Jacobson DM. Diagnostic criteria for idiopathic intracranial hypertension. Neurology 59, 1492-1495 (2002).
3. Lueck C, McIlwaine G. Interventions for idiopathic intracranial hypertension. Cochrane Database Syst. Rev. CD003434 (2005).
4. Garrett JH, Corbett JJ, Braswell R. The incidence of idiopathic intracranial hypertension in Mississippi. In: North American Neuro-Ophthalmology Society. Orlando, FL, USA 269 (2004).
5. Jacobs DA, Corbett JJ, Balcer LJ. Annual incidence of idiopathic intracranial hypertension (IIH) in the Philadelphia area. In: North American Neuro-Ophthalmology Society. Orlando, FL, USA 286 (2004).
6. Daniels AB, Liu GT, Volpe NJ et al. Profiles of obesity, weight gain, and quality of life in idiopathic intracranial hypertension (pseudotumor cerebri). Am. J. Ophthalmol. 143, 635-641 (2007).
7. Evans RW. Diagnostic testing for chronic daily headache. Curr. Pain Headache Rep. 11(1), 47-52 (2007).
8. Wall M. The headache profile of idiopathic intracranial hypertension. Cephalalgia 10, 331-335 (1990).
9. Volcy M, Tepper SJ. Cluster-like headache secondary to idiopathic intracranial hypertension. Cephalalgia 26(7), 883-886 (2006).
10. Suryadevara AC, Fattal M, Woods CI. Nontraumatic cerebrospinal fluid rhinorrhea as a result of pseudotumor cerebri. Am. J. Otolaryngol. 28, 242-246 (2007).
11. Huna-Baron R, Landau K, Rosenberg ML, Warren FA, Kupersmith MJ. Unilateral swollen disc due to increased intracranial pressure. Neurology 56, 1588-1590 (2001).
12. Friedman DI. Pseudotumor cerebri. Neurol. Clin. 22, 99-131 (2004).
13. Banick R, Lin D, Miller NR. Prevalence of Chiari I malformation and cerebellar ectopia in patients with pseudotumor cerebri. J. Neurol. Sci. 247, 71-75 (2006).
14. Farb RI, Vanek I, Scott JN et al. Idiopathic intracranial hypertension. The prevalence and morphology of sinovenous stenosis. Neurology 60, 1418-1424 (2003).
15. King JO, Mitchell PJ, Thomson KR, Tress BM. Manometry combined with cervical puncture in idiopathic intracranial hypertension. Neurology 58, 26-30 (2002).
16. Rohr A, Dörner L, Stingele R et al. Reversibility of venous sinus obstruction in idiopathic intracranial hypertension. AJNR Am. J. Neuroradiol. 28, 656-659 (2007).
17. Bono F, Messina D, Gilberto C et al. Bilateral transverse sinus stenosis predicts IIH without papilledema in patients with migraine. Neurology 67, 419-423 (2006).
18. Rangwalla LM, Liu GT. Pediatric idiopathic intracranial hypertension. Surv. Ophthalmol. 52(6), 597-617 (2007).
19. Neville L, Egan RA. Frequency and amplitude of elevation of cerebrospinal fluid resting pressure by the Valsalva maneuver. Can. J. Ophthalmol. 40, 775-777 (2005).
20. Biousse V, Ameri A, Bousser M-G. Isolated intracranial hypertension as the only sign of cerebral venous thrombosis. Neurology 53, 1537-1542 (1999).
21. Corbett JJ, Digre KB. Idiopathic intracranial hypertension. An answer to, "the chicken or the egg?" Neurology 58, 5-6 (2002).
22. Friedman DI. Cerebral venous pressure, gastric bypass surgery and dural venous sinus stenting in idiopathic intracranial hypertension. J. Neuroophthalmol. 26, 61-64 (2006).
23. Warner JEA, Bernstein PS, Yemelyanov A et al. Vitamin A in the cerebrospinal fluid of patients with and without idiopathic intracranial hypertension. Ann. Neurol. 52, 647-650 (2002).
24. Jacobson DM, Berg R, Wall M et al. Serum vitamin A concentration is elevated in idiopathic intracranial hypertension. Neurology 53, 1114-1118 (1999).
25. Johnston M, Zakharov A, Papaiconomou C, Salmasi G, Armstrong D. Evidence of connections between cerebrospinal fluid and nasal lymphatic vessels in humans, non-human primates and other mammalian species. Cerebrospinal Fluid Res. 1(2), 1-13 (2004).
26. Killer HE, Jaggi GP, Flammer J et al. Cerebrospinal fluid dynamics between the intracranial and subarachnoid space of the optic nerve. Is it always bidirectional? Brain 130, 514-520 (2007).
27. Kupersmith MJ, Gamell L, Turbin R, Spiegel P, Wall M. Effects of weight loss on the course of idiopathic intracranial hypertension in women. Neurology 50, 1094-1098 (1998).
28. Friedman DI, Streeten DHP. Idiopathic intracranial hypertension and orthostatic edema may share a common pathogenesis. Neurology 50, 1099-1104 (1998).
29. Finsterer J, Földy D, Fertl E. Topiramate resolves headache from pseudotumor cerebri. J. Pain Symptom Manage. 32(5), 401-402 (2006).
30. Alore PL, Jay WM, Macken MP. Topiramate, pseudotumor cerebri, weight-loss and glaucoma: an ophthalmologic perspective. Semin. Ophthalmol. 21(1), 15-17 (2006).
31. Fraunfelder FW, Fraunfelder FT, Keates EU. Topiramate-associated acute, bilateral secondary angle-closure glaucoma. Ophthalmology 111, 109-111 (2004).
32. Friedman DI, Rausch EA. Headache diagnoses in patients with treated idiopathic intracranial hypertension. Neurology 58, 1551-1553 (2002).
33. Liu GT, Kay MD, Bienfang DC, Schatz NJ. Pseudotumor cerebri associated with corticosteroid withdrawal in inflammatory bowel disease. Am. J. Ophthalmol. 117, 352-357 (1994).
34. Kleinschmidt JJ, Digre KB, Hanover R. Idiopathic intracranial hypertension. Relationship to depression, anxiety, and quality of life. Neurology 54, 319-324 (2000).
35. Kelman SE, Sergott RC, Cioffi GA et al. Modified optic nerve decompression in patients with functioning lumboperitoneal shunts and progressive visual loss. Ophthalmology 98, 1449-1453 (1991).
36. Sergott RC, Savino PJ, Bosley TM. Optic nerve sheath decompression: a clinical review and proposed pathophysiologic mechanism. Aust. N. Z. Ophthalmol. 18, 365-373 (1990).
37. Spoor TC, McHenry JG. Long-term effectiveness of optic nerve sheath decompression for pseudotumor cerebri. Arch. Ophthalmol. 111, 632-635 (1993).
38. Thuente DD, Buckley EG. Pediatric optic nerve sheath decompression. Ophthalmology 112(4), 724-727 (2005).
39. Chandrasekaran S, McCluskey P, Minassian D, Assaad N. Visual outcome for optic nerve sheath fenestration in pseudotumor cerebri and related conditions. Clin. Experiment. Ophthalmol. 34(7), 661-665 (2006).
40. Brodsky MC, Rettele GA. Protracted postsurgical blindness with visual recovery following optic nerve sheath fenestration. Arch. Ophthalmol. 116, 107-108 (1998).
41. Curry WT Jr, Butler WE, Barker FG 2nd. Rapidly rising incidence of cerebrospinal fluid shunting procedures for idiopathic intracranial hypertension in the United States, 1988-2002. Neurosurgery 57(1), 97-108 (2005).
42. Eggenberger ER, Miller NR, Vitale S. Lumboperitoneal shunt for the treatment of pseudotumor cerebri. Neurology 46, 1524-1530 (1996).
43. Rosenberg ML, Corbett JJ, Smith C et al. Cerebrospinal diversion procedures for pseudotumor cerebri. Neurology 43, 1071-1072 (1993).
44. McGirt MJ, Woodworth G, Thomas G et al. Cerebrospinal fluid shunt placement for pseudotumor cerebri-associated intractable headache: predictors of treatment response and analysis of long term outcomes. J. Neurosurg. 101, 627-632 (2004).
45. Liu GT, Volpe NJ, Schatz NJ et al. Severe sudden visual loss caused by pseudotumor cerebri and lumboperitoneal shunt failure. Am. J. Ophthalmol. 122, 129-131 (1996).
46. Higgins JNP, Cousins C, Owler BK, Sarkies N, Pickard JD. Idiopathic intracranial hypertension: 12 cases treated by venous sinus stenting. J. Neurol. Neurosurg. Psychiatr. 74, 1662-1666 (2003).
47. Owler BK, Parker G, Halmagyi GM et al. Cranial venous outflow obstruction and pseudotumor cerebri syndrome. Adv. Tech. Stand. Neurosurg. 30, 108-174 (2005).
48. Owler BK, Parker G, Halmagyi GM et al. Pseudotumor cerebri syndrome: venous sinus obstruction and its treatment with stent placement. J. Neurosurg. 98, 1045-1055 (2003).
49. Balcer LJ, Liu GT, Forman S et al. Idiopathic intracranial hypertension: Relation of age and obesity in children. Neurology 52, 870-872 (1999).
50. Lessell S. Pediatric pseudotumor cerebri (idiopathic intracranial hypertension). Surv. Ophthalmol. 37, 155-166 (1992).
51. Cinciripini GS, Donahue S, Borchert MS. Idiopathic intracranial hypertension in prepubertal pediatric patients: characteristics, treatment and outcome. Am. J. Ophthalmol. 127, 178-182 (1999).
52. Weig SG. Asymptomatic idiopathic intracranial hypertension in young children. J. Child Neurol. 17(3), 239-241 (2002).
53. Thambisetty M, Lavin PJ, Newman NJ, Biousse V. Fulminant idiopathic intracranial hypertension. Neurology 68(3), 229-232 (2007).
54. Wang S-J, Silberstein SD, Patterson S, Young WB. Idiopathic intracranial hypertension without papilledema. A case-control study in a headache center. Neurology 51, 245-249 (1998).
55. Scher AI, Stewart WF, Ricci JA, Lipton RB. Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain 106(1-2), 81-89 (2003).